HIF1A and breast carcinoma: Moreover, we confirmed that antagomir-21 could suppress miR-21 expression in breast tumor tissues, which is involved in inhibiting angiogenesis by targeting HIF-1α/VEGF/VEGFR2 signaling pathway in breast cancer.